Children Are Not Small Adults: Specific Findings in Statin Exposure and Response in a Growing Population.
作者信息
Wagner Jonathan B
机构信息
Ward Family Heart Center, Children's Mercy, Kansas City, Missouri, USA.
Division of Clinical Pharmacology, Medical Toxicology and Therapeutic Innovation, Children's Mercy, Kansas City, Missouri, USA.
出版信息
Clin Pharmacol Ther. 2019 Aug;106(2):278-280. doi: 10.1002/cpt.1431. Epub 2019 Apr 10.
Abstract
摘要
相似文献
1
Children Are Not Small Adults: Specific Findings in Statin Exposure and Response in a Growing Population.儿童并非缩小版成人：成长人群中他汀类药物暴露与反应的特定发现
Clin Pharmacol Ther. 2019 Aug;106(2):278-280. doi: 10.1002/cpt.1431. Epub 2019 Apr 10.
2
Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy.高脂血症的个体化医学：药物遗传学在他汀类药物治疗中的作用。
Ann Med. 2020 Dec;52(8):462-470. doi: 10.1080/07853890.2020.1800074. Epub 2020 Aug 24.
3
Pharmacogenetic study of statin therapy and cholesterol reduction.他汀类药物治疗与胆固醇降低的药物遗传学研究。
Curr Atheroscler Rep. 2005 May;7(3):177-8.
4
Genetic polymorphisms and statin therapy.基因多态性与他汀类药物治疗
JAMA. 2004 Sep 15;292(11):1302-3. doi: 10.1001/jama.292.11.1302-b.
5
Pharmacogenomics of cholesterol-lowering therapy.降胆固醇治疗的药物基因组学
Vascul Pharmacol. 2006 Feb;44(2):75-89. doi: 10.1016/j.vph.2005.07.012. Epub 2005 Dec 5.
6
Clinical implications of pharmacogenomics of statin treatment.他汀类药物治疗的药物基因组学的临床意义。
Pharmacogenomics J. 2006 Nov-Dec;6(6):360-74. doi: 10.1038/sj.tpj.6500384. Epub 2006 Mar 21.
7
Impact of Genetic Variation on Pravastatin Systemic Exposure in Pediatric Hypercholesterolemia.遗传变异对儿科高胆固醇血症患者普伐他汀系统暴露的影响。
Clin Pharmacol Ther. 2019 Jun;105(6):1501-1512. doi: 10.1002/cpt.1330. Epub 2019 Feb 25.
8
Pharmacogenetics and statin-related myopathy: what do we know?药物遗传学与他汀类药物相关肌病：我们了解多少？
Pharmacogenomics. 2020 Aug;21(12):821-825. doi: 10.2217/pgs-2020-0041. Epub 2020 Jul 29.
9
Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of Statins.实验室医学在高胆固醇血症治疗的临床决策支持中的应用：他汀类药物的药物遗传学
Clin Lab Med. 2016 Sep;36(3):473-91. doi: 10.1016/j.cll.2016.05.010. Epub 2016 Jun 24.
10
The role of genotyping in lowering cardiovascular risk.基因分型在降低心血管风险中的作用。
Pharmacogenomics. 2021 Jul;22(11):649-656. doi: 10.2217/pgs-2021-0075. Epub 2021 Jul 1.
引用本文的文献
1
Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.用于β地中海贫血和镰状细胞病的药物的药物基因组学：从基础研究到临床应用
Int J Mol Sci. 2024 Apr 12;25(8):4263. doi: 10.3390/ijms25084263.
2
Pharmacogenetics to Predict Adverse Events Associated With Antidepressants.药物遗传学预测与抗抑郁药相关的不良事件。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-0957.
3
Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.回顾性分析一家学术儿童医院的药物遗传学检测。
Clin Transl Sci. 2021 Jan;14(1):412-421. doi: 10.1111/cts.12895. Epub 2020 Oct 15.
4
Pharmacogenetics: Chasing Perfection.药物遗传学：追求完美。
Clin Pharmacol Ther. 2019 Aug;106(2):265-270. doi: 10.1002/cpt.1511.
本文引用的文献
1
Impact of Genetic Variation on Pravastatin Systemic Exposure in Pediatric Hypercholesterolemia.遗传变异对儿科高胆固醇血症患者普伐他汀系统暴露的影响。
Clin Pharmacol Ther. 2019 Jun;105(6):1501-1512. doi: 10.1002/cpt.1330. Epub 2019 Feb 25.
2
Impact of SLCO1B1 Genotype on Pediatric Simvastatin Acid Pharmacokinetics.SLCO1B1 基因型对儿科辛伐他汀酸药代动力学的影响。
J Clin Pharmacol. 2018 Jun;58(6):823-833. doi: 10.1002/jcph.1080. Epub 2018 Feb 22.
3
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.通过液相色谱-串联质谱蛋白质组学定量分析肝脏药物转运体的个体发生。
Clin Pharmacol Ther. 2016 Oct;100(4):362-70. doi: 10.1002/cpt.409. Epub 2016 Aug 13.
4
The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.临床药物基因组学实施联盟关于SLCO1B1与辛伐他汀所致肌病的指南：2014年更新版
Clin Pharmacol Ther. 2014 Oct;96(4):423-8. doi: 10.1038/clpt.2014.125. Epub 2014 Jun 11.
5
HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism.HNRNPA1 调控 HMGCR 可变剪接并调节细胞内胆固醇代谢。
Hum Mol Genet. 2014 Jan 15;23(2):319-32. doi: 10.1093/hmg/ddt422. Epub 2013 Sep 2.
6
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.SLCO1B1基因多态性显著影响辛伐他汀酸的药代动力学。
Pharmacogenet Genomics. 2006 Dec;16(12):873-9. doi: 10.1097/01.fpc.0000230416.82349.90.
7
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).高血浆普伐他汀浓度与有机阴离子转运多肽-C（OATP-C，SLCO1B1）的单核苷酸多态性和单倍型相关。
Pharmacogenetics. 2004 Jul;14(7):429-40. doi: 10.1097/01.fpc.0000114750.08559.32.
Zotero 插件